Eine
vor 35 Jahren begonnene Studie zeigt, dass die Einnahme
einer Antibabypille keine nachteiligen Auswirkungen
auf die Sterblichkeit der teilnehmenden 17.000 Frauen
hatte. Eine leichte Erhöhung der Sterblichkeit an
Muttermundkrebs wurde mehr als ausgeglichen durch
eine verminderte Sterblichkeit an Gebärmutter- und
Eierstockkrebs.
Die extreme
Schädlichkeit des Zigarettenrauchens wurde abermals
bestätigt: die Sterblichkeit erhöht sich beim Konsum
von mehr als 15 Zigaretten pro Tag um über 50%.
Insgesamt
hatten die Autoren der Studie den Eindruck, dass die
Gesamtsterblichkeit bei den Pillennutzerinnen eher
niedriger war als bei den Nicht-Nutzerinnen oraler
Kontrazeptiva..

The Lancet, Issue 19 July 2003
UK
STUDY UNDERLINES SAFETY OF CONTRACEPTIVE PILL FOR NON-SMOKERS
Latest
findings from a UK study established 35 years ago
to assess the health outcomes for women using the contraceptive
pill during the 1970s and 1980s are published in this
week's issue of THE LANCET. The key finding from the study
highlights no increased risk of death from any cause (except
cervical cancer) for non-smoking pill users; however among
heavy smokers the study findings suggest a moderate increase
in the risk of death from ischaemic heart disease in women
who used the contraceptive pill compared with non-smoking
pill users.
As part of the Oxford Family Planning Association study,
Martin Vessey from the Institute of Health Sciences,
Oxford, UK, and colleagues examined death associated with
oral contraceptive use and cigarette smoking-issues of
public health importance because both use of such contraceptives
and smoking are common in women of childbearing age.
Around
17,000 women who were aged 25-39 years between
1968 and 1974 and who used oral contraceptives,
a diaphragm, or an intrauterine device took part in the
study. Follow-up data were available up to the end of
2000 by which time 889 women had died.
As
expected, an increase in death from
cervical cancer among women who had ever used the oral
contraceptive pill was more than counterbalanced by a
reduction in risk of death from other uterinecancers and
ovarian cancer. There was no
overall increased risk of death from all causes
considered together among women who used oral contraceptives
(regardless of duration of pill use) compared with women
in the study who had never used oral contraceptives; the
data suggest that the overall risk
of death might be lower among oral contraceptive users
than among non-users. Oral contraceptives had some
adverse effect on deaths from ischaemic heart disease
in women who were heavy smokers. In comparison
with non-smokers, there was an increase in death from
all causes of around 25% for light smokers and more than
a doubling of death risk from all causes for heavy smokers
(women who smoked more than 15 cigarettes a day). Martin
Vessey comments: "The oral contraceptives widely
used in the 1970s and early 1980s have now been shown
to have no adverse effect on overall
mortality in three major cohort studies including
many deaths and large numbers of women with long-term
oral contraceptive use. This is a reassuring finding for
many older women today. Although the results should not
be extrapolated directly to contemporary low-dose pills,
they do nonetheless offer considerable encouragement.
The
effects of cigarette smoking, especially
heavy smoking, have again been shown to be very harmful,
more than doubling mortality from all causes even in young
women in the Oxford FPA study."
Contact:
Emeritus Professor Martin P Vessey, Division of Public
Health & Primary
Health, Care, Institute of Health Sciences, Old Road,
Headington, Oxford OX3 7LF, UK; T) +44 (0)1865 226994
(secretary); F) +44 (0)1865 226993; E) martin.vessey@dphpc.ox.ac.uk
Issue 19 July 2003
|